HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzanne Havard Selected Research

PF-5212372

3/2012Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suzanne Havard Research Topics

Disease

1Neoplasms (Cancer)
07/2012
1Colorectal Neoplasms (Colorectal Cancer)
07/2012
1Respiratory Hypersensitivity
03/2012
1Lung Diseases (Lung Disease)
03/2012
1Asthma (Bronchial Asthma)
03/2012
1Inflammation (Inflammations)
03/2012

Drug/Important Bio-Agent (IBA)

1Keratins (Keratin)IBA
07/2012
1Detergents (Detergent)IBA
07/2012
1Cytoskeletal ProteinsIBA
07/2012
1ProteomeIBA
07/2012
1PF-5212372IBA
03/2012
1Phospholipases (Phospholipase)IBA
03/2012
1Prostaglandins DIBA
03/2012
1EicosanoidsIBA
03/2012
1Adenosine Monophosphate (AMP)IBA
03/2012
1Pharmaceutical PreparationsIBA
03/2012
1EnzymesIBA
03/2012

Therapy/Procedure

1Therapeutics
03/2012